Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Renfeng Shan is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastrointestinal cancers, particularly through comparative analyses of robotic and laparoscopic surgery. His major contributions lie in systematically evaluating the long-term oncological outcomes and safety profiles of these approaches. In his landmark 2020 meta-analysis (51 citations), Dr. Shan demonstrated that robotic mesorectal excision for rectal cancer yields short-term outcomes comparable to conventional laparoscopy, while highlighting the critical need for further investigation into long-term oncological results. His 2019 updated systematic review (20 citations) on gastric cancer surgery provided a rigorous comparison between robotic and laparoscopic gastrectomy, clarifying their relative effectiveness and safety. These works have become essential references for surgeons navigating the adoption of robotic platforms, directly influencing clinical decision-making and surgical training. By synthesizing evidence from hundreds of patients, Dr. Shan has helped establish benchmarks for evaluating new technologies in oncologic surgery. His research continues to shape the evolution of minimally invasive oncology, offering clarity in a rapidly advancing field.